Mighty Capital Fund III

United States
Seed
Share

About Mighty Capital Fund III

Mighty Capital closes $91M Fund III, tripling in size based on six IPOs and a product-led investing edge. Seed and early-stage focus.

Investment Focus

Location / RegionUnited States
Funding StageSeed
Industry Focus
Enterprise Software
Saas

Investor Signals Profile

active

Sweet Spot

Ex-PM founders, B2B SaaS, product-led growth, early stage

product-led growth
B2B enterprise
early product signals
ex-PM founders
AI infrastructure
Web3 / fintech infra
HR tech / employee experience

Bullish Signals

Fund III closed $91M, oversubscribedblog
6 IPOs, 60x exit, $1B+ valueblog
Public pension LP added — institutional validationblog
Groq portfolio: $20B NVIDIA partnershipblog
PeopleReign: AI employee service bettwitter
Inovia Discovery Fund LP — co-investor signaltwitter
Accern: 2x Gartner Hype Cycle recognitiontwitter
WSJ feature: repeatability narrative confirmedlinkedin
Fund III = 3x size of prior fundlinkedin

Contrarian Signals

Sub-$100M fund, niche thesis riskblog
Fund size creep could dilute disciplineblog
Portfolio details undisclosed at closeblog
Web3/blockchain bets alongside PLG thesistwitter

Founder Do's

Ship from world-class product org (OpenAI, Stripe, Figma)
Build with product moat, not just distribution
Show early product-market fit signals
B2B with PLG motion
Team of 2–4, product-native

Founder Don'ts

Sales-led, not product-led growth
No product pedigree in founding team
Consumer or non-B2B focus

Key GPs & Partners

SM
SC Moatti
Co-Founder & General Partner
ex-foundercommunity-builderthesis-driven
JV
Jennifer Vancini
Co-Founder & General Partner
metrics-drivenpatient-capital

Unlock Investor Signals

$29/month for full signal access. Cancel anytime.

Fund Overview

Fund Size$91M
Saves0

Key People

SC Moatti, Jennifer Vancini

SC MoattiCo-Founder & General Partner
Jennifer VanciniCo-Founder & General Partner

Related Funds

Omega Funds Fund IX

$647M
United States
Growth
Biotech, Digital Health, Therapeutics
Fund Manager:Otello Stampacchia, Francesco Draetta, Claudio Nessi
Growth
Biotech
Digital Health
Therapeutics

Oncology Venture I.

$30M
United States
Pre Seed
Saas
Fund Manager:Ben Freeberg
Pre Seed
Saas

TPG Secondaries Fund

$1800M
United States
Seed
Saas
Fund Manager:Matt Jones, Michael Woolhouse
Seed
Saas